Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-114961
Filing Date
2018-04-12
Accepted
2018-04-12 08:45:57
Documents
18
Period of Report
2018-05-23
Effectiveness Date
2018-04-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A d489684ddef14a.htm DEF 14A 900620
2 GRAPHIC g4896841.jpg GRAPHIC 35313
3 GRAPHIC g4896842.jpg GRAPHIC 27105
4 GRAPHIC g4896843.jpg GRAPHIC 12374
5 GRAPHIC g4896845.jpg GRAPHIC 25917
6 GRAPHIC g489684g01w73.jpg GRAPHIC 14957
7 GRAPHIC g489684g02e02.jpg GRAPHIC 42661
8 GRAPHIC g489684g07w89.jpg GRAPHIC 48045
9 GRAPHIC g489684g26y93.jpg GRAPHIC 121348
10 GRAPHIC g489684g28x28.jpg GRAPHIC 52088
11 GRAPHIC g489684g56c18.jpg GRAPHIC 77223
12 GRAPHIC g489684g59s99.jpg GRAPHIC 51966
13 GRAPHIC g489684g87b92.jpg GRAPHIC 24955
14 GRAPHIC g489684g89i56.jpg GRAPHIC 43945
15 GRAPHIC g489684g90v60.jpg GRAPHIC 48001
16 GRAPHIC g489684g99m98.jpg GRAPHIC 24531
17 GRAPHIC g489684img004a.jpg GRAPHIC 18531
18 GRAPHIC g489684img006.jpg GRAPHIC 9054
  Complete submission text file 0001193125-18-114961.txt   1815914
Mailing Address 210 E. GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 210 E. GRAND AVE SOUTH SAN FRANCISCO CA 94080 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0102
Type: DEF 14A | Act: 34 | File No.: 000-30235 | Film No.: 18751227
SIC: 8731 Services-Commercial Physical & Biological Research